Current Neuropharmacology : Impact Factor & More
eISSN: 1875-6190pISSN: 1570-159X
Share this on:
Key Metrics
CiteScore 
11.7
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology
SNIP
2.3
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Neuropharmacology
Current Neuropharmacology Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Neuropharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Neuropharmacology
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study.
- 9 May 2026
- Current neuropharmacology
The Mechanisms and Research Progress of Electroacupuncture Modulation of the Anterior Cingulate Cortex in Alleviating Paclitaxel-induced Pain and Cognitive Impairment.
- 9 May 2026
- Current neuropharmacology
Serum Cyclic Pentapeptide Cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) as a Candidate Diagnostic Biomarker for Depression-Anxiety Comorbidity.
- 9 May 2026
- Current neuropharmacology
N-acetylcysteine, Acetyl-L-carnitine, and Citicoline: A Potential Synergism in Neurological and Psychiatric Disorders.
- 9 May 2026
- Current neuropharmacology
Exploring Mitochondrial Dysfunction and Protective Therapeutic Approaches to Counteract Its Role in Alzheimer's Disease Progression.
- 8 May 2026
- Current neuropharmacology
Exploring the Gut Microbiome as a Promising Frontier in Alzheimer's Disease Therapy.
- 8 May 2026
- Current neuropharmacology
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study.
- 9 May 2026
- Current neuropharmacology
The Mechanisms and Research Progress of Electroacupuncture Modulation of the Anterior Cingulate Cortex in Alleviating Paclitaxel-induced Pain and Cognitive Impairment.
- 9 May 2026
- Current neuropharmacology
Serum Cyclic Pentapeptide Cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) as a Candidate Diagnostic Biomarker for Depression-Anxiety Comorbidity.
- 9 May 2026
- Current neuropharmacology
N-acetylcysteine, Acetyl-L-carnitine, and Citicoline: A Potential Synergism in Neurological and Psychiatric Disorders.
- 9 May 2026
- Current neuropharmacology
Exploring Mitochondrial Dysfunction and Protective Therapeutic Approaches to Counteract Its Role in Alzheimer's Disease Progression.
- 8 May 2026
- Current neuropharmacology
Exploring the Gut Microbiome as a Promising Frontier in Alzheimer's Disease Therapy.
- 8 May 2026
- Current neuropharmacology
FAQs on Current Neuropharmacology
How long has Current Neuropharmacology been actively publishing? 
What is the publishing frequency of Current Neuropharmacology?
How many articles did Current Neuropharmacology publish last year?
What is the eISSN & pISSN for Current Neuropharmacology?
What is Citescore for Current Neuropharmacology?
What is SNIP score for Current Neuropharmacology?
What is the SJR for Current Neuropharmacology?
Who is the publisher of Current Neuropharmacology?
